Nat. Rev. Cardiol. doi: /nrcardio

Slides:



Advertisements
Similar presentations
Nat. Rev. Cardiol. doi: /nrcardio
Advertisements

Figure 1 Initial management of a patient with acute heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Binding properties of P2Y12-receptor inhibitors
Figure 5 BMI and cardiorespiratory fitness levels
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 BMI and mortality in patients with heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Global rates of sodium, fruit, and vegetable intake
Figure 1 Anatomy of the femoral artery
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition
Figure 3 3D printing of aortic and mitral valves
Figure 8 4D magnetic resonance imaging patterns
Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 6 Pharmacodynamic profile of switching between clopidogrel and ticagrelor therapy: results from the RESPOND study Figure 6| Pharmacodynamic profile.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Cardiovascular risk and disease across the life-course
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Figure 1 Decision tree integrating the assessment,
Figure 4 TAVI for bicuspid aortic valve disease
Figure 2 Global cost of HF per capita in 2012
Figure 2 A patient with aortic stenosis and mitral regurgitation
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Milestones in coronary angioplasty
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Challenges for big data applications in cardiovascular care
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Observational studies on multiple treatment strategies
Figure 5 Bioresorbable vascular scaffold apposition and strut coverage
Nat. Rev. Cardiol. doi: /nrcardio
Figure 6 The neurogenic components of angina
Matthew Oster et al. JACC 2019;73:
Figure 9 Management of atrial fibrillation
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Impaired mitochondrial capacity and function in heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Distribution of systolic pulmonary artery pressure (Ppa) in relation to functional class (FC) for congenital heart disease patients with a) atrial septal.
Nat. Rev. Cardiol. doi: /nrcardio
Presentation transcript:

Nat. Rev. Cardiol. doi:10.1038/nrcardio.2013.127 Figure 1 Percutaneous closure of ostium secundum defects in adult patients Permission for part a obtained from Wiley © Amin, Z. Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc. Interv. 68, 778–787 (2006). Permission for part c obtained from St. Jude Medical, Inc., MN, USA. Permission for part d obtained from W. L. Gore & Associates, Inc., AZ, USA Singh, H. S. et al. (2013) Interventional cardiology in adults with congenital heart disease Nat. Rev. Cardiol. doi:10.1038/nrcardio.2013.127